Adriana E. Tron

1.8k total citations
28 papers, 864 citations indexed

About

Adriana E. Tron is a scholar working on Molecular Biology, Hematology and Oncology. According to data from OpenAlex, Adriana E. Tron has authored 28 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Hematology and 7 papers in Oncology. Recurrent topics in Adriana E. Tron's work include Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (5 papers) and Cancer Mechanisms and Therapy (5 papers). Adriana E. Tron is often cited by papers focused on Multiple Myeloma Research and Treatments (9 papers), Acute Myeloid Leukemia Research (5 papers) and Cancer Mechanisms and Therapy (5 papers). Adriana E. Tron collaborates with scholars based in United States, Canada and Argentina. Adriana E. Tron's co-authors include Alexander W. Hird, Daniel H. González, James A. DeCaprio, Carlos W. Bertoncini, Raquel L. Chan, Hiroyuki Inuzuka, Shavali Shaik, Wenyi Wei, David M. Duda and Takehiro Arai and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Adriana E. Tron

25 papers receiving 858 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adriana E. Tron United States 16 706 199 172 111 78 28 864
Lior Golomb Israel 11 726 1.0× 242 1.2× 91 0.5× 89 0.8× 78 1.0× 14 924
Jutta Deckert United States 11 666 0.9× 295 1.5× 57 0.3× 126 1.1× 75 1.0× 28 1.0k
Astrid Clarke United States 11 715 1.0× 171 0.9× 94 0.5× 234 2.1× 141 1.8× 27 1000
Jocelyn H. Wright United States 13 869 1.2× 229 1.2× 107 0.6× 142 1.3× 175 2.2× 17 1.2k
Guikai Wu United States 18 825 1.2× 245 1.2× 80 0.5× 148 1.3× 312 4.0× 22 1.2k
Özge Gürsoy-Yüzügüllü United States 12 1.0k 1.5× 240 1.2× 116 0.7× 80 0.7× 36 0.5× 12 1.2k
Francesca Lorenzin Italy 9 976 1.4× 160 0.8× 166 1.0× 55 0.5× 46 0.6× 14 1.1k
Jeff Lightfoot Canada 10 728 1.0× 141 0.7× 87 0.5× 119 1.1× 67 0.9× 15 925
Susanne Steggerda United States 11 469 0.7× 93 0.5× 68 0.4× 102 0.9× 65 0.8× 23 695

Countries citing papers authored by Adriana E. Tron

Since Specialization
Citations

This map shows the geographic impact of Adriana E. Tron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adriana E. Tron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adriana E. Tron more than expected).

Fields of papers citing papers by Adriana E. Tron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adriana E. Tron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adriana E. Tron. The network helps show where Adriana E. Tron may publish in the future.

Co-authorship network of co-authors of Adriana E. Tron

This figure shows the co-authorship network connecting the top 25 collaborators of Adriana E. Tron. A scholar is included among the top collaborators of Adriana E. Tron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adriana E. Tron. Adriana E. Tron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cathelin, Séverine, David Dai, Éric Grignano, et al.. (2025). Single-cell proteogenomic analysis of clonal evolution in PDX models of AML treated with IDH inhibitors. PubMed. 3(1). 100182–100182.
2.
Bent, Martin J. van den, Ingo K. Mellinghoff, Mehdi Touat, et al.. (2024). 10311- ACT-19 A GLOBAL, RANDOMIZED, DOUBLE-BLINDED, PHASE 3 STUDY OF VORASIDENIB VERSUS PLACEBO IN PATIENTS WITH ADULT-TYPE DIFFUSE GLIOMA WITH AN IDH1/2 MUTATION (INDIGO): UPDATED EFFICACY RESULTS. Neuro-Oncology Advances. 6(Supplement_4). iv9–iv9. 2 indexed citations
3.
Cathelin, Séverine, David Dai, Éric Grignano, et al.. (2024). Single-Cell Proteogenomic Analysis of Clonal Evolution in Patient-Derived Xenograft Models of AML Treated with IDH Inhibitors. Blood. 144(Supplement 1). 4995–4995.
4.
DiNardo, Courtney D., Stéphane de Botton, Daniel A. Pollyea, et al.. (2023). Safety, efficacy, and PK/PD of vorasidenib in previously treated patients with mIDH1/2 hematologic malignancies: A phase 1 study. American Journal of Hematology. 98(9). E233–E236. 5 indexed citations
5.
Chuntova, Pavlina, Akane Yamamichi, Rohini Narayanaswamy, et al.. (2022). Inhibition of D-2HG leads to upregulation of a proinflammatory gene signature in a novel HLA-A2/HLA-DR1 transgenic mouse model of IDH1R132H-expressing glioma. Journal for ImmunoTherapy of Cancer. 10(5). e004644–e004644. 23 indexed citations
6.
Goliaei, Ardeshir, Adriana E. Tron, Matthew A. Belmonte, et al.. (2020). Multiscale Model Identifies Improved Schedule for Treatment of Acute Myeloid Leukemia In Vitro With the Mcl‐1 Inhibitor AZD5991. CPT Pharmacometrics & Systems Pharmacology. 9(10). 561–570. 3 indexed citations
7.
Montero, Joan, Cécile Gstalder, Daniel J. Kim, et al.. (2019). Destabilization of NOXA mRNA as a common resistance mechanism to targeted therapies. Nature Communications. 10(1). 5157–5157. 42 indexed citations
8.
Hird, Alexander W. & Adriana E. Tron. (2019). Recent advances in the development of Mcl-1 inhibitors for cancer therapy. Pharmacology & Therapeutics. 198. 59–67. 106 indexed citations
9.
Natarajan, Karthika, Rena G. Lapidus, Rossana Trotta, et al.. (2017). Concurrent Inhibition of Pim and FLT3 Kinases Enhances Apoptosis of FLT3-ITD Acute Myeloid Leukemia Cells through Increased Mcl-1 Proteasomal Degradation. Clinical Cancer Research. 24(1). 234–247. 36 indexed citations
10.
11.
Trotta, Rossana, Karthika Natarajan, Feyruz V. Rassool, et al.. (2016). Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress. Oncotarget. 7(30). 48280–48295. 15 indexed citations
12.
Zhong, Jiateng, Shavali Shaik, Lixin Wan, et al.. (2013). SCFβ-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration. Oncotarget. 4(12). 2339–2353. 42 indexed citations
13.
Duda, David M., Jennifer L. Olszewski, Adriana E. Tron, et al.. (2012). Structure of a Glomulin-RBX1-CUL1 Complex: Inhibition of a RING E3 Ligase through Masking of Its E2-Binding Surface. Molecular Cell. 47(3). 371–382. 65 indexed citations
14.
Min, Sang Hyun, Alan W. Lau, Tae Ho Lee, et al.. (2012). Negative Regulation of the Stability and Tumor Suppressor Function of Fbw7 by the Pin1 Prolyl Isomerase. Molecular Cell. 46(6). 771–783. 131 indexed citations
15.
Tron, Adriana E., Takehiro Arai, David M. Duda, et al.. (2012). The Glomuvenous Malformation Protein Glomulin Binds Rbx1 and Regulates Cullin RING Ligase-Mediated Turnover of Fbw7. Molecular Cell. 46(1). 67–78. 49 indexed citations
16.
Gao, Daming, Lixin Wan, Hiroyuki Inuzuka, et al.. (2010). Rictor Forms a Complex with Cullin-1 to Promote SGK1 Ubiquitination and Destruction. Molecular Cell. 39(5). 797–808. 74 indexed citations
17.
Skaar, Jeffrey R., Laurence Florens, Takeya Tsutsumi, et al.. (2007). PARC and CUL7 Form Atypical Cullin RING Ligase Complexes. Cancer Research. 67(5). 2006–2014. 56 indexed citations
18.
Tron, Adriana E., Carlos W. Bertoncini, Raquel L. Chan, & Daniel H. González. (2002). Redox Regulation of Plant Homeodomain Transcription Factors. Journal of Biological Chemistry. 277(38). 34800–34807. 80 indexed citations
19.
Palena, Claudia, Adriana E. Tron, Carlos W. Bertoncini, Daniel H. González, & Raquel L. Chan. (2001). Positively charged residues at the N-terminal arm of the homeodomain are required for efficient DNA binding by homeodomain-leucine zipper proteins11Edited by M. Yaniv. Journal of Molecular Biology. 308(1). 39–47. 34 indexed citations
20.
Tron, Adriana E.. (2001). Combinatorial interactions of two amino acids with a single base pair define target site specificity in plant dimeric homeodomain proteins. Nucleic Acids Research. 29(23). 4866–4872. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lior Golomb Breakdown of academic impact, for papers by Jutta Deckert Breakdown of academic impact, for papers by Astrid Clarke Breakdown of academic impact, for papers by Jocelyn H. Wright Breakdown of academic impact, for papers by Guikai Wu Breakdown of academic impact, for papers by Özge Gürsoy-Yüzügüllü Breakdown of academic impact, for papers by Francesca Lorenzin Breakdown of academic impact, for papers by Jeff Lightfoot Breakdown of academic impact, for papers by Susanne Steggerda
Rankless by CCL
2026